Literature DB >> 24558508

Intrahepatic cholangiocarcinoma: are we doing the right thing?

Basile Njei1.   

Abstract

Entities:  

Year:  2014        PMID： 24558508      PMCID： PMC3924760     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  11 in total

1.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.

Authors:  T Patel
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

2.  Matched survival data in a co-twin control design.

Authors:  Mette Gerster; Mia Madsen; Per Kragh Andersen
Journal:  Lifetime Data Anal       Date:  2013-07-18       Impact factor: 1.588

3.  Between-within models for survival analysis.

Authors:  Arvid Sjölander; Paul Lichtenstein; Henrik Larsson; Yudi Pawitan
Journal:  Stat Med       Date:  2013-03-03       Impact factor: 2.373

Review 4.  Cholangiocarcinoma: modern advances in understanding a deadly old disease.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  J Hepatol       Date:  2006-09-25       Impact factor: 25.083

5.  Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma.

Authors:  Henrik Petrowsky; Peer Wildbrett; Daniela B Husarik; Thomas F Hany; Simona Tam; Wolfram Jochum; Pierre-Alain Clavien
Journal:  J Hepatol       Date:  2006-04-19       Impact factor: 25.083

6.  18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.

Authors:  Carlos U Corvera; Leslie H Blumgart; Timothy Akhurst; Ronald P DeMatteo; Michael D'Angelica; Yuman Fong; William Robert Jarnagin
Journal:  J Am Coll Surg       Date:  2007-10-01       Impact factor: 6.113

7.  Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.

Authors:  Hashem B El-Serag; Eric A Engels; Ola Landgren; Elizabeth Chiao; Louise Henderson; Harshinie C Amaratunge; Thomas P Giordano
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

8.  Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.

Authors:  Young-Jin Kim; Mijin Yun; Woo Jung Lee; Kyung Sik Kim; Jong Doo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-08-07       Impact factor: 9.236

9.  Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

Authors:  Yasser H Shaib; Jessica A Davila; Kathryn McGlynn; Hashem B El-Serag
Journal:  J Hepatol       Date:  2004-03       Impact factor: 25.083

10.  Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma.

Authors:  S A Khan; M B Toledano; S D Taylor-Robinson
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.